In vitro cytotoxicity, apoptosis, DNA-binding, and antioxidant activity studies of ruthenium (II) complexes.

Two new ligands maip (1) (maip = 2-(3-aminophenyl)imizado[4,5-f][1,10]phenanthroline), paip (2) (paip = 2-(4-aminophenyl)imidazo[4,5-f][1,10]phenanthroline), and their ruthenium (II) complexes [Ru(phen)(2)(maip)](ClO(4))(2) (3) and [Ru(phen)(2)(paip)](ClO(4))(2) (4) (phen = 1,10-phenanthroline) have been synthesized and characterized. The cytotoxicity of these compounds was evaluated by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The apoptosis assay was carried out with acridine orange/ethidium bromide staining methods. The DNA-binding behaviors of complexes 3 and 4 were investigated by viscosity measurements, thermal denaturation, photocleavage, and spectroscopic methods. The results show that the two complexes intercalate into the base pairs of DNA. In the presence of a complex, apoptosis of BEL-7402 cells was observed. Experiments show that these compounds exhibit antioxidant activity against hydroxyl radicals.

[1]  Jun-hua Yao,et al.  Synthesis, characterization, photocleavage of DNA and cytotoxicity of ruthenium(II) mixed-ligand complexes , 2009 .

[2]  L. Ji,et al.  Synthesis, DNA-binding and photocleavage studies of ruthenium complexes [Ru(bpy)2(mitatp)]2+ and [Ru(bpy)2(nitatp)]2+. , 2009, Journal of inorganic biochemistry.

[3]  R. Parthasarathi,et al.  Synthesis and DNA-binding studies of two ruthenium(II) complexes of an intercalating ligand. , 2009, European journal of medicinal chemistry.

[4]  L. Ji,et al.  Synthesis, crystal structure and DNA-binding studies of a Ru(II) complex containing two main ligands , 2008 .

[5]  Bao-dui Wang,et al.  Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand. , 2008, European journal of medicinal chemistry.

[6]  Shuo Shi,et al.  Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. , 2008, Journal of inorganic biochemistry.

[7]  Wen-jie Zheng,et al.  Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes. , 2008, Journal of inorganic biochemistry.

[8]  L. Ji,et al.  Synthesis, characterization, DNA-binding and spectral properties of complexes [Ru(L)4(dppz)]2+ (L=Im and MeIm). , 2008, Journal of inorganic biochemistry.

[9]  F. Gao,et al.  Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes , 2007, JBIC Journal of Biological Inorganic Chemistry.

[10]  M. Jakupec,et al.  From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). , 2006, Journal of inorganic biochemistry.

[11]  Mei Han,et al.  Ruthenium(II) complex of Hbopip: synthesis, characterization, pH-induced luminescence "off-on-off" switch, and avid binding to DNA. , 2006, The journal of physical chemistry. B.

[12]  Jun Yu Li,et al.  Electronic effect of different positions of the -NO2 group on the DNA-intercalator of chiral complexes [Ru(bpy)2L]2+ (L =o-npip, m-npip and p-npip). , 2005, Dalton transactions.

[13]  C. Moucheron,et al.  Photoadducts of Metallic Compounds with Nucleic Acids − Role Played by the Photoelectron Transfer Process and by the TAP and HAT Ligands in the RuII Complexes , 2004 .

[14]  J. Hickman,et al.  Apoptosis induced by anticancer drugs , 1992, Cancer and Metastasis Reviews.

[15]  Jim A. Thomas,et al.  Kinetically inert transition metal complexes that reversibly bind to DNA. , 2003, Chemical Society reviews.

[16]  P. Sadler,et al.  Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. , 2003, Journal of the American Chemical Society.

[17]  C. Che,et al.  Syntheses of ruthenium(II) quinonediimine complexes of cyclam and characterization of their DNA-binding activities and cytotoxicity. , 2002, Inorganic chemistry.

[18]  E. Steck,et al.  Reactions of Phenanthraquinone and Retenequinone with Aldehydes and Ammonium Acetate in Acetic Acid Solution1 , 2002 .

[19]  G. Sava,et al.  Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma , 2001, Metal-based drugs.

[20]  G. Sava,et al.  Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. , 2000, Pharmacology & toxicology.

[21]  D. Odom,et al.  Recognition and reaction of metallointercalators with DNA. , 1999, Chemical reviews.

[22]  L. Ji,et al.  Synthesis, DNA-binding and DNA-mediated luminescence quenching of Ru(II) polypyridine complexes , 1999 .

[23]  Robert D. Goldman,et al.  Cells: a laboratory manual , 1997 .

[24]  Jian-Zhong Wu,et al.  Synthesis, characterization and luminiscent DNA-binding study of a series of ruthenium complexes containing 2-arylimidazo[f]1,10-phenanthroline , 1997 .

[25]  J. Chaires,et al.  Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. , 1993, Biochemistry.

[26]  S. Rokita,et al.  Nickel(III)‐Promoted DNA Cleavage with Ambient Dioxygen , 1993 .

[27]  W. Sundquist,et al.  The coordination chemistry of platinum anticancer drugs and related compounds with DNA , 1990 .

[28]  Michael T. Carter,et al.  Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine , 1989 .

[29]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[30]  D. Crothers,et al.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid. , 1982, Biochemistry.

[31]  R. Lorentzen,et al.  Role of superoxide in deoxyribonucleic acid strand scission. , 1980, Biochemistry.

[32]  B. P. Sullivan,et al.  Mixed phosphine 2,2'-bipyridine complexes of ruthenium , 1978 .

[33]  J. McGhee.  Theoretical calculations of the helix–coil transition of DNA in the presence of large, cooperatively binding ligands , 1976, Biopolymers.

[34]  P. Merkel,et al.  UNAMBIGUOUS EVIDENCE FOR THE PARTICIPATION OF SINGLET OXYGEN ( 1 δ) IN PHOTODYNAMIC OXIDATION OF AMINO ACIDS , 1972, Photochemistry and photobiology.

[35]  H. Eisenberg,et al.  Viscosity and sedimentation study of sonicated DNA–proflavine complexes , 1969 .

[36]  M. Waring,et al.  Complex formation between ethidium bromide and nucleic acids. , 1965, Journal of molecular biology.

[37]  J. Marmur.  A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .

[38]  S. Rice,et al.  A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid , 1954 .